📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

Hemodialysis

126.3 mL/min

Highly Dialyzable

Significant removal expected. Half-life: 92 min. Consider post-dialysis supplementation. Short half-life suggests rapid endogenous clearance may minimize impact of HD.

Data Used:
✅ protein_binding, molar_mass, mw_factor, half_life
⚠️ Missing: vd

Free fraction: 0.86 Mw factor: 0.85 Vd factor: 0.8 Hl factor: 0.8 Half life: 92 min Half life category: Short (1-4h)

🫀

Peritoneal Dialysis

2.0 mL/min

Low PD Clearance

Minimal removal expected. No supplementation needed. Half-life: 92 min.

Data Used:
✅ protein_binding, molar_mass, half_life

Free fraction: 0.86 Half life: 92 min Half life category: Short (1-4h)

🔄

Plasmapheresis (TPE)

Unable to Assess

Insufficient data for TPE risk assessment. Protein binding and Vd required.

Data Used:
✅ protein_binding, half_life
⚠️ Missing: vd

Half life: 92 min Half life category: Short (1-4h)

🧪

Hemoadsorption

Cannot Assess

Vd data required for hemoadsorption effectiveness assessment.

Data Used:
✅ half_life
⚠️ Missing: vd

Half life: 92 min Half life category: Short (1-4h)

📋 Summary of Estimates

Modality	Clearance/Value	Half-Life	Classification	Data Quality
Hemodialysis	126.3 mL/min	92 min	Highly Dialyzable	Partial Data
Peritoneal Dialysis	2.0 mL/min	92 min	Low PD Clearance	Complete Data
Plasmapheresis (TPE)	Unable to Assess	92 min	N/A	Partial Data
Hemoadsorption	Cannot Assess	92 min	N/A	Partial Data

📌 Important Notes

Hemodialysis: Estimates based on high-flux dialyzer (urea clearance 270 mL/min), Qb 300 mL/min, 4-hour session.
Peritoneal Dialysis: Estimates based on CAPD (Continuous Ambulatory Peritoneal Dialysis).
TPE: Risk assessment based on protein binding and volume of distribution.
Hemoadsorption: Effectiveness based on volume of distribution. Most effective for drugs with Vd < 0.2 L/kg.
Data Quality: Estimates with missing data use default assumptions. Consider adding missing data for more accurate predictions.
Clinical Note: These are descriptive estimates only. Always consult clinical guidelines and monitor drug levels when available.